Dr. Herbst on the Impact of Frontline Immunotherapy in Lung Cancer – OncLive
Dr. Herbst on the Impact of Frontline Immunotherapy in Lung CancerOncLiveRoy S. Herbst, MD, PhD, professor of Medicine, chief of Medical Oncology, Yale Cancer Center and Smilow Cancer Hospital, discusses the impact that immunotherapy has had on the fro… Continue reading
